Skip to search formSkip to main contentSkip to account menu

ZD 1839

Known as: ZD1839 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Activation of the epidermal growth factor receptor (EGFR) and downstream signaling pathways have been implicated in causing… 
2007
2007
La funcion esencial del receptor del factor de crecimiento epidermico (REGF) en diversos tipos de tumores solidos lo ha… 
Review
2005
Review
2005
Purpose:We investigated the molecular effect of the epidermal growth factor receptor (EGFR) inhibitors erlotinib and gefitinib in… 
2004
2004
Purpose: A worldwide compassionate-use program has enabled >42,000 patients with advanced non-small cell lung cancer (NSCLC) to… 
2004
2004
7367 Background: Preclinical and clinical studies including IDEAL 1 and 2 showed that oral gefitinib (Iressa, ZD1839) is an… 
Review
2003
Review
2003
A number of agents targeting components of pathways and processes critical to neoplastic transformation and progression are…